Cytel expands biostatistics software business in Barcelona, Paris

Cambridge, MA-based biometrics CRO Cytel opened up shop in two European locations this week: Barcelona and Paris. This brings its overall footprint across Europe, the U.S. and India to 800 staff in 10 offices.

Cytel offers clinical research software, and the new locations, particularly the Barcelona office, will enable it to build up its data science arm, according to a release. The expansion in Paris, where it already had an office, will bring together biostatisticians and statistical programmers.

“The development of a dedicated data science group is a natural progression for Cytel, as an established leader in the fields of biostatistics and data analysis,” strategic consulting vice president Yannis Jemiai said. “There is now a wealth of genomic, proteomic, diagnostic and electronic data available with the power to transform healthcare. We will apply our significant statistical know-how to the mission of unlocking its potential.”

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Founded almost 30 years ago, the company’s clinical trial design and analysis software is used by top pharma companies as an industry standard, as well as by the FDA. Its biggest software products include East, Compass, StatXact and LogXact.

Read more on

Suggested Articles

Bayer CEO Werner Baumann stressed “less and less trust in society" for technology advances as a hurdle for pharma companies working on gene editing.

As GlaxoSmithKline looks to start a 23andMe-partnered test this year, the Big Pharma is increasingly looking to tech for its R&D.

LabCorp has unveiled a new suite of cell and gene therapy development offerings from Covance as it looks to get into this burgeoning area.